ArticleFrontiers in oncology2026

Factors influencing oncologists' decisions for germline BRCA testing and adjuvant therapy selection in HER2-negative early breast cancer.

Qixin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.